Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Foley & Lardner
- Armstrong Teasdale
- Krantz & Berman
- Linklaters LLP
- Cicala Law Firm
- Norton Rose
- Cozen O'Connor
- Steven Williams Law
- Tostrud Law Group
- Kirkland & Ellis
- Steptoe LLP
- Wilson Sonsini
- Cuneo Gilbert
- Freedman Boyd
- Girard Sharp
- Cleary Gottlieb
- Weil Gotshal
- NastLaw
- Pogust Goodhead
- Spiro Harrison
- Welsh & Recker
- DeCotiis FitzPatrick
- Faegre Drinker
- Lite DePalma
- Neal & Harwell
- Stueve Siegel
- Kaplan Fox
- Williams & Connolly
- Berger Montague
- Miller Shah LLP
- Schertler Onorato
- Lieff Cabraser
- Motley Rice
- Cole Schotz
- DiCello Levitt
- Baker Botts
- Fox Rothschild
- Larson King
- Furth Salem
- Hausfeld LLP
- Lockridge Grindal
- Simpson Thacher & Bartlett LLP
- Troutman Pepper
- Calcaterra Pollack
- White and Williams
- Morrison Foerster
- Morgan Lewis
- Napoli Shkolnik
- Arnold & Porter
- Dugan Law Firm
- Nussbaum Law Group
- Kasowitz Benson
- DLA Piper
- Hogan Lovells
- Hagens Berman
- Miller & Chevalier
- Reed Smith
- Marks O'Neill
- Schneider Wallace
- Joseph Saveri Law Firm
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Cotchett Pitre
- Crowell & Moring
- Lowey Dannenberg
- Fine Kaplan
- Grant & Eisenhofer
Companies
- LifeWallet
- Walgreens Boots Alliance Inc.
- The Harvard Drug Group LLC
- Health Care Service Corp.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Bausch Health Cos. Inc.
- Cardinal Health Inc.
Government Agencies
Sectors & Industries:
-
December 02, 2019
AGs Used Privileged Doc Again In Price-Fix Case: Pharma Co.
Heritage Pharmaceuticals has told a Pennsylvania federal court that a group of states and territories led by Connecticut included a privileged email in the latest complaint filed in the sprawling generic-drug price-fixing litigation, even after the company tried to claw the document back.
-
October 08, 2019
Attys Denied Fee Set-Aside In Generics Antitrust Case
Lawyers for two sets of litigants suing generic-drug makers in a price-fixing class action can't get a 10% set-aside from any future damages that parties taking their own direct actions ultimately win, a Pennsylvania federal judge has ruled, at least for now.
-
September 16, 2019
Generic Cos. Pan 'Irrelevant' Doc Demands In Price-Fix Case
Numerous generic-drug makers entangled in a vast price-fixing suit in Pennsylvania federal court are slamming a special master's plan for discovery, claiming that his recommendation would force them to produce millions of documents the companies view as irrelevant.
-
August 15, 2019
Drugmakers Can't Ax MDL's 'Overarching Conspiracy' Claims
A Pennsylvania federal judge refused on Thursday to throw out allegations in multidistrict litigation that Actavis, Teva, Mylan and other drugmakers engaged in a "broad overarching conspiracy" to fix generic-drug prices, saying the allegations are sufficiently pled and discovery is needed to determine if they're true.
-
July 29, 2019
Leaked Email In Price-Fixing Case Is Privileged, Heritage Says
Heritage Pharmaceuticals told a Pennsylvania federal court Friday that an email it turned over to Connecticut's attorney general that was later used in the sprawling generic drug price-fixing litigation is privileged and should have been treated as confidential.
-
July 22, 2019
Conn. Denies Leaking Heritage Doc In Generic-Drug Case
Connecticut's attorney general, one of several state AGs suing generic-drug companies alleging that they fixed prices, is defending the decision to refer in the complaint to an email suggesting Heritage Pharmaceuticals and other firms tried to obstruct a congressional probe into the generic-drug industry.
-
July 10, 2019
Heritage Says Conn. Leaked Email About Congressional Probe
Heritage Pharmaceuticals accused Connecticut's attorney general on Tuesday of including a privileged email in a new generic-drug price-fixing complaint that suggests the company tried to obstruct a congressional investigation.
-
June 26, 2019
McKesson Dodges Generic Drug Price-Fix MDL For Now
A Pennsylvania federal judge nixed claims Wednesday that McKesson Corp. earned billions of dollars by cooperating with an industry-wide price-fixing conspiracy among generic-drug makers, ruling that a putative class' allegations in the multidistrict litigation are impermissible suppositions.
-
June 25, 2019
Big Pharma's Biggest New Cases Of 2019: Midyear Report
Multibillion-dollar lawsuits targeting major drugmakers emerged with astonishing frequency during the first half of 2019, threatening civil and criminal liability for all manner of alleged wheeling and dealing. Here, Law360 highlights the latest developments and upcoming action in the pharmaceutical world's hottest new cases.
-
June 24, 2019
Drugmakers' Emails, Calls Show Price-Fix Coverup, AGs Say
Unredacted emails and phone records show Teva Pharmaceuticals, Pfizer Inc. and 18 other major U.S. drug manufacturers conspiring in an industrywide price-fixing scheme to keep the cost of hundreds of generic drugs artificially high, according to a complaint unsealed Monday by the Maryland attorney general's office.